Mannitol-Containing Pellets Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Mannitol-Containing Pellets

Mannitol-Containing Pellets are pharmaceutical excipient-based multiparticulate pellets in which D-mannitol is incorporated as one component of the pellet formulation. Unlike a pure Mannitol Pellet, the term “Mannitol-Containing” does not establish that mannitol is the major or only component. The actual mannitol percentage must therefore be defined by the finished formulation.

D-Mannitol has CAS 69-65-8, molecular formula C₆H₁₄O₆, and molecular weight 182.17 g/mol. The current USP-NF monograph specifies 97.0%–102.0% mannitol on a dried basis for the mannitol excipient itself.

Mannitol can be incorporated into pellet formulations together with other pharmaceutical excipients. Published research has evaluated mannitol-containing pellets prepared by extrusion-spheronization and demonstrated that changing the mannitol proportion can affect pellet properties and release behavior.

Key Features

  • Pharmaceutical-grade mannitol-containing pellet system
  • Multiparticulate pharmaceutical formulation
  • Mannitol incorporated as a formulation component
  • Suitable for formulation development
  • Suitable for capsule-filling applications
  • Suitable for further coating or layering
  • Product-specific mannitol loading
  • Product-specific pellet size and physical characteristics
  • Pharmaceutical manufacturing applications
  • Bulk supply and supplier support for formulation requirements

Applications

Mannitol-Containing Pellets can be considered for:

  • Multiparticulate oral formulations
  • Capsule-filling applications
  • Pharmaceutical formulation development
  • Pellet-core formulations
  • Further coating and functional processing
  • Active-ingredient layering
  • Immediate-release formulation development
  • Modified-release formulation development

Product Characteristics

The finished characteristics depend on the mannitol percentage, other excipients, binder system, pelletization process and intended application.

Mannitol-containing pellet formulations have been investigated using extrusion-spheronization, with changes in mannitol content influencing pellet morphology, mechanical properties and release characteristics.

Therefore, the final pellet specification should be established for the actual formulation rather than applying the specification of pure mannitol to the complete pellet.

Why Mannitol-Containing Pellets from Swapnroop?

  • Pharmaceutical-grade mannitol-containing formulation platform
  • Product-specific mannitol incorporation
  • Multiparticulate pellet format
  • Suitable for formulation development
  • Suitable for further coating and layering
  • Product-specific quality parameters
  • Suitable for capsule-filling applications
  • Quality-focused pellet processing
  • Bulk manufacturing and supplier support

Packaging & Supply

Mannitol-Containing Pellets can be supplied for pharmaceutical formulation development and bulk manufacturing requirements. Mannitol loading, pellet size, composition, packaging configuration and finished-product specifications should be confirmed against the applicable product specification and COA.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 97.0% – 103.0%
Loss on Drying NMT 0.5%
Residue on Ignition NMT 0.1%
Water Content NMT 0.5%
Specific Rotation +23° to +25
Melting Point 165–170°
Get Bulk Quote via WhatsApp